Go Pro
NASDAQ:THMO

ThermoGenesis (THMO) Stock Price, News & Analysis

ThermoGenesis logo

About ThermoGenesis Stock (NASDAQ:THMO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
991 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is a biotechnology company that has developed automated technologies for processing, preserving and storing biological materials used in cell-based therapies and regenerative medicine. Its work has primarily focused on systems designed to improve the collection and preparation of therapeutic cells while reducing manual handling.

The company’s product portfolio has historically included the AXP AutoXpress Platform, an automated system for processing cord blood and other cellular products, and the BioArchive System, an automated cryogenic storage and retrieval platform. ThermoGenesis has also offered related consumables and equipment intended for use by cord-blood banks, cell-therapy organizations and medical institutions.

ThermoGenesis has served customers and partners in the United States and international markets, including Europe and Asia. Publicly available information about its current operating activities and leadership is limited, and the company’s products and business focus have changed over time.

AI Generated. May Contain Errors.

Receive THMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THMO Stock News Headlines

ThermoGenesis Holdings Inc.
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day. Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone. See how investors are positioning ahead of this closely watched IPO.tc pixel
North American Morning Briefing: Stock Futures, -2-
See More Headlines

THMO Stock Analysis - Frequently Asked Questions

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) released its quarterly earnings results on Friday, November, 12th. The company reported ($6.75) earnings per share for the quarter, missing analysts' consensus estimates of ($3.60) by $3.15. The firm had revenue of $3.16 million for the quarter, compared to analyst estimates of $3.06 million.

ThermoGenesis shares reverse split on Friday, December 23rd 2022.The 1-45 reverse split was announced on Friday, December 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of THMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ThermoGenesis investors own include FuelCell Energy (FCEL), Teladoc Health (TDOC), Zoom Communications (ZM), Bionano Genomics (BNGO), Co-Diagnostics (CODX), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/12/2021
Today
9/24/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Laboratory apparatus & furniture
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:THMO
CIK
811212
Employees
25
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$9.61 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.99) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,953,000
Free Float
1,750,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
1.09

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:THMO) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners